These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 20798216)

  • 1. Influence of particle size on the pathology and efficacy of vaccination in a murine model of inhalational anthrax.
    Thomas R; Davies C; Nunez A; Hibbs S; Flick-Smith H; Eastaugh L; Smither S; Gates A; Oyston P; Atkins T; Eley S
    J Med Microbiol; 2010 Dec; 59(Pt 12):1415-1427. PubMed ID: 20798216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Particle-size dependent effects in the Balb/c murine model of inhalational melioidosis.
    Thomas RJ; Davies C; Nunez A; Hibbs S; Eastaugh L; Harding S; Jordan J; Barnes K; Oyston P; Eley S
    Front Cell Infect Microbiol; 2012; 2():101. PubMed ID: 22919690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhalational anthrax (Ames aerosol) in naïve and vaccinated New Zealand rabbits: characterizing the spread of bacteria from lung deposition to bacteremia.
    Gutting BW; Nichols TL; Channel SR; Gearhart JM; Andrews GA; Berger AE; Mackie RS; Watson BJ; Taft SC; Overheim KA; Sherwood RL
    Front Cell Infect Microbiol; 2012; 2():87. PubMed ID: 22919678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pathology of experimental anthrax in rabbits exposed by inhalation and subcutaneous inoculation.
    Zaucha GM; Pitt LM; Estep J; Ivins BE; Friedlander AM
    Arch Pathol Lab Med; 1998 Nov; 122(11):982-92. PubMed ID: 9822127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of antibiotic efficacy against Bacillus anthracis in a mouse aerosol challenge model.
    Heine HS; Bassett J; Miller L; Hartings JM; Ivins BE; Pitt ML; Fritz D; Norris SL; Byrne WR
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1373-9. PubMed ID: 17296745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human monoclonal antibody AVP-21D9 to protective antigen reduces dissemination of the Bacillus anthracis Ames strain from the lungs in a rabbit model.
    Peterson JW; Comer JE; Baze WB; Noffsinger DM; Wenglikowski A; Walberg KG; Hardcastle J; Pawlik J; Bush K; Taormina J; Moen S; Thomas J; Chatuev BM; Sower L; Chopra AK; Stanberry LR; Sawada R; Scholz WW; Sircar J
    Infect Immun; 2007 Jul; 75(7):3414-24. PubMed ID: 17452469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathology of inhalation anthrax in cynomolgus monkeys (Macaca fascicularis).
    Vasconcelos D; Barnewall R; Babin M; Hunt R; Estep J; Nielsen C; Carnes R; Carney J
    Lab Invest; 2003 Aug; 83(8):1201-9. PubMed ID: 12920249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary involvement of pharynx and peyer's patch in inhalational and intestinal anthrax.
    Glomski IJ; Piris-Gimenez A; Huerre M; Mock M; Goossens PL
    PLoS Pathog; 2007 Jun; 3(6):e76. PubMed ID: 17542645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro correlate of immunity in a rabbit model of inhalational anthrax.
    Pitt ML; Little SF; Ivins BE; Fellows P; Barth J; Hewetson J; Gibbs P; Dertzbaugh M; Friedlander AM
    Vaccine; 2001 Sep; 19(32):4768-73. PubMed ID: 11535328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An intranasal vaccine targeting both the Bacillus anthracis toxin and bacterium provides protection against aerosol spore challenge in rabbits.
    Wimer-Mackin S; Hinchcliffe M; Petrie CR; Warwood SJ; Tino WT; Williams MS; Stenz JP; Cheff A; Richardson C
    Vaccine; 2006 May; 24(18):3953-63. PubMed ID: 16530302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral administration of a Salmonella enterica-based vaccine expressing Bacillus anthracis protective antigen confers protection against aerosolized B. anthracis.
    Stokes MG; Titball RW; Neeson BN; Galen JE; Walker NJ; Stagg AJ; Jenner DC; Thwaite JE; Nataro JP; Baillie LW; Atkins HS
    Infect Immun; 2007 Apr; 75(4):1827-34. PubMed ID: 17145938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacillus anthracis has two independent bottlenecks that are dependent on the portal of entry in an intranasal model of inhalational infection.
    Lowe DE; Ernst SM; Zito C; Ya J; Glomski IJ
    Infect Immun; 2013 Dec; 81(12):4408-20. PubMed ID: 24042112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity of recombinant protective antigen and efficacy against aerosol challenge with anthrax.
    Williamson ED; Hodgson I; Walker NJ; Topping AW; Duchars MG; Mott JM; Estep J; Lebutt C; Flick-Smith HC; Jones HE; Li H; Quinn CP
    Infect Immun; 2005 Sep; 73(9):5978-87. PubMed ID: 16113318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucosal immunization with a novel nanoemulsion-based recombinant anthrax protective antigen vaccine protects against Bacillus anthracis spore challenge.
    Bielinska AU; Janczak KW; Landers JJ; Makidon P; Sower LE; Peterson JW; Baker JR
    Infect Immun; 2007 Aug; 75(8):4020-9. PubMed ID: 17502384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathology of inhalational anthrax animal models.
    Twenhafel NA
    Vet Pathol; 2010 Sep; 47(5):819-30. PubMed ID: 20656900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nasal immunization with anthrax protective antigen protein adjuvanted with polyriboinosinic-polyribocytidylic acid induced strong mucosal and systemic immunities.
    Sloat BR; Cui Z
    Pharm Res; 2006 Jun; 23(6):1217-26. PubMed ID: 16718616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intranasal administration of dry powder anthrax vaccine provides protection against lethal aerosol spore challenge.
    Huang J; Mikszta JA; Ferriter MS; Jiang G; Harvey NG; Dyas B; Roy CJ; Ulrich RG; Sullivan VJ
    Hum Vaccin; 2007; 3(3):90-3. PubMed ID: 17375001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of early immune response-survival relationship in cynomolgus macaques after Anthrax Vaccine Adsorbed vaccination and Bacillus anthracis spore challenge.
    Sivko GS; Stark GV; Tordoff KP; Taylor KL; Glaze E; VanRaden M; Schiffer JM; Hewitt JA; Quinn CP; Nuzum EO
    Vaccine; 2016 Dec; 34(51):6518-6528. PubMed ID: 27155494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defining a serological correlate of protection in rabbits for a recombinant anthrax vaccine.
    Little SF; Ivins BE; Fellows PF; Pitt ML; Norris SL; Andrews GP
    Vaccine; 2004 Jan; 22(3-4):422-30. PubMed ID: 14670324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A synthetic peptide vaccine directed against the 2ß2-2ß3 loop of domain 2 of protective antigen protects rabbits from inhalation anthrax.
    Oscherwitz J; Yu F; Cease KB
    J Immunol; 2010 Sep; 185(6):3661-8. PubMed ID: 20696862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.